Bristol-Myers Squibb Executive and Leadership Team

Candice Huntsman, the Chief of Staff, Cell Therapy Commercial Strategy & Operations Lead at Bristol-Myers Squibb, directs the execution of complex market access initiatives for advanced oncology treatments. Overseeing the integration of commercial roadmaps, Huntsman ensures that cell therapy portfolios reach patients across diverse global markets. This leadership role involves coordinating cross-functional teams to align manufacturing output with clinical demand. By optimizing operational workflows, the Chief of Staff, Cell Therapy Commercial Strategy & Operations Lead drives efficiency within the high-stakes biopharmaceutical landscape. Candice Huntsman also facilitates communication between executive leadership and regional commercial units to maintain a unified strategic vision. Through rigorous analysis of market trends, the organization secures a competitive advantage in the rapidly evolving field of cancer immunotherapy. Ultimately, Huntsman supports the delivery of transformative medical solutions to patients requiring specialized care.

Benjamin Kingscott, the Manager, Chief Technology Officer Plant Engineering at Bristol-Myers Squibb, architects the technical infrastructure required for large-scale pharmaceutical manufacturing. Managing the engineering standards for production facilities, Kingscott ensures that all technical systems meet stringent global regulatory requirements. This role involves overseeing the implementation of advanced automation technologies to enhance production capacity for critical medications. As the Manager, Chief Technology Officer Plant Engineering, Kingscott collaborates with internal stakeholders to modernize facility operations and reduce downtime. Benjamin Kingscott also drives the adoption of sustainable engineering practices across the manufacturing network to improve operational efficiency. By maintaining high standards for plant reliability, the organization guarantees consistent supply chain performance for essential cardiovascular and virology treatments. Through technical oversight, Kingscott secures the operational integrity of the company's global production footprint, ensuring that scientific breakthroughs translate into reliable, high-quality therapeutic products for patients worldwide.

Hena Abidi, the S & O Lead For Rdc People Organization Chief of Staff at Bristol-Myers Squibb, manages the strategic alignment of human capital within the research and development division. Coordinating organizational design initiatives, Abidi ensures that the workforce possesses the necessary expertise to advance the company's oncology and immunoscience pipelines. This leadership role involves streamlining internal processes to foster a culture of scientific innovation and collaboration. As the S & O Lead For Rdc People Organization Chief of Staff, Abidi facilitates communication between research teams and executive leadership to prioritize high-impact projects. Hena Abidi also oversees the implementation of talent development programs that support long-term growth in the biopharmaceutical sector. By optimizing organizational structures, the organization maintains a dynamic environment where researchers can effectively address unmet medical needs. Through strategic personnel management, Abidi secures the operational capacity required to sustain the company's position as a leader in medical discovery.

Sharon Tuccillo, the Senior Executive Associate To Chief Information Officer at Bristol-Myers Squibb, manages the administrative and strategic workflow for the information technology division. Coordinating high-level projects, Tuccillo ensures that digital transformation initiatives align with the company's broader goals in pharmaceutical research and manufacturing. This role involves facilitating communication between the Chief Information Officer and various department heads to streamline data management and cybersecurity protocols. As the Senior Executive Associate To Chief Information Officer, Tuccillo oversees the scheduling and execution of critical technology reviews that support global operations. Sharon Tuccillo also monitors the progress of digital infrastructure upgrades that enable efficient distribution of prescription medications. By maintaining organizational focus on key IT objectives, the organization enhances its ability to leverage data for medical breakthroughs. Through diligent coordination, Tuccillo supports the technological foundation necessary for the company to address serious patient needs across multiple therapeutic domains.

Amy Silverstein, the Chief of Staff To Chief Medical Officer, Head of Development at Bristol-Myers Squibb, directs the strategic operations of the clinical development organization. Overseeing the coordination of complex drug development programs, Silverstein ensures that research efforts remain focused on high-priority therapeutic areas like oncology and virology. This leadership role involves managing the interface between the Chief Medical Officer and global clinical teams to accelerate the path from discovery to patient access. As the Chief of Staff To Chief Medical Officer, Head of Development, Silverstein facilitates the alignment of clinical trial strategies with regulatory milestones. Amy Silverstein also monitors the progress of strategic alliances that expand the company's research capabilities. By optimizing the development pipeline, the organization maintains a robust portfolio of innovative treatments. Through rigorous operational oversight, Silverstein secures the successful translation of scientific research into meaningful therapeutic advances for patients facing significant health challenges.

Moses Munyua, the Groc Senior Communications Specialist & Chief Technology Officer, Emd at Bristol-Myers Squibb, manages the technical communication strategy for the company's engineering and manufacturing divisions. Architecting digital platforms for internal knowledge sharing, Munyua ensures that technical teams across the globe remain aligned on production standards and innovation goals. This role involves translating complex technological advancements into clear strategic narratives for internal stakeholders. As the Groc Senior Communications Specialist & Chief Technology Officer, Emd, Munyua oversees the integration of new digital tools that enhance collaboration within the manufacturing network. Moses Munyua also drives the adoption of data-driven communication practices to improve operational transparency. By bridging the gap between technical engineering and corporate strategy, the organization accelerates the development of new treatment options. Through effective communication and technical leadership, Munyua secures the operational efficiency required to deliver life-saving medications to patients in major markets worldwide.

Shane Chunko, the Chief of Staff To the Chief Strategy Officer at Bristol-Myers Squibb, manages the execution of long-term corporate initiatives and strategic planning. Coordinating the development of market-entry strategies, Chunko ensures that the organization effectively addresses unmet medical needs in oncology and cardiovascular disease. This leadership role involves facilitating communication between the Chief Strategy Officer and the executive board to refine the company's competitive positioning. As the Chief of Staff To the Chief Strategy Officer, Chunko oversees the analysis of global market trends to identify new opportunities for growth and partnership. Shane Chunko also monitors the progress of strategic alliances that complement internal research capabilities. By maintaining a focus on high-impact business objectives, the organization sustains its leadership in the biopharmaceutical industry. Through rigorous strategic coordination, Chunko secures the alignment of resources necessary to translate scientific breakthroughs into long-term financial and medical success.

Yograj Jadav, the Manager, Chief Technology Officer MSAT Process Validation (CAR- T) at Bristol-Myers Squibb, directs the technical validation of manufacturing processes for advanced cell therapies. Overseeing the rigorous testing of production protocols, Jadav ensures that CAR-T treatments meet the highest standards of safety and efficacy. This role involves managing the technical interface between research and commercial manufacturing to ensure scalable production of personalized cancer immunotherapies. As the Manager, Chief Technology Officer MSAT Process Validation (CAR- T), Jadav leads the implementation of process improvements that reduce variability in complex biological manufacturing. Yograj Jadav also collaborates with quality assurance teams to maintain compliance with global regulatory requirements. By optimizing the validation lifecycle, the organization accelerates the delivery of innovative cancer treatments to patients. Through technical expertise in process validation, Jadav secures the operational reliability required to support the company's commitment to addressing serious patient needs in oncology.

Debra Golding, the Senior Executive Associate, Chief of Staff and Compliance at Bristol-Myers Squibb, manages the administrative and regulatory oversight for executive operations. Coordinating the implementation of internal compliance policies, Golding ensures that all business activities align with the highest ethical and legal standards in the pharmaceutical industry. This role involves facilitating communication between executive leadership and legal departments to mitigate operational risks. As the Senior Executive Associate, Chief of Staff and Compliance, Golding oversees the execution of governance frameworks that support the company's global research and manufacturing activities. Debra Golding also monitors the effectiveness of compliance training programs across the organization. By maintaining a culture of integrity, the organization protects its reputation and ensures the sustainable delivery of therapeutic solutions. Through diligent oversight of administrative and compliance functions, Golding secures the operational stability necessary for the company to focus on its mission of discovering and developing life-saving medications.

Tiffany Paglaiccetti, the Excellence Performance Lead, Corporate Functions & Services Chief of Staff at Bristol-Myers Squibb, directs the optimization of internal business processes to enhance organizational efficiency. Overseeing the performance metrics for corporate services, Paglaiccetti ensures that administrative and operational functions support the company's scientific mission. This leadership role involves coordinating cross-functional initiatives to streamline workflows and reduce operational costs across the global footprint. As the Excellence Performance Lead, Corporate Functions & Services Chief of Staff, Paglaiccetti facilitates the implementation of continuous improvement programs that drive excellence in service delivery. Tiffany Paglaiccetti also monitors the alignment of corporate functions with the strategic goals of the research and development divisions. By fostering a culture of performance, the organization maintains the agility required to address complex patient needs. Through rigorous process management, Paglaiccetti secures the operational foundation necessary for the company to translate scientific breakthroughs into meaningful therapeutic advances.